We studied the toxic action of mercury (II) chloride (10.9 μM) on cultured IMR-32 neuroblastoma cells and possible protective effects of the antioxidant thiotriazolinum and cardioprotector mildronate (concentrations of the former agent in the medium 0.01-10.0 mg/ml). Isolated addition of thiotriazolinum and a combination of thiotriazolinum + mildronate to the medium did not cause dramatic negative effects (number of dead cells at all concentrations used did not exceed 7–10% of the population under control conditions). Thiotriazolinum in concentrations of 0.1 and 0.01 mg/ml demonstrated a significant neuroprotective activity against the toxic action of mercury (II) chloride: the mean number of living cells under such conditions of culturing was, on average, about 83.0% vs 54.7% in the case where isolated action of HgCl2 was used. The mean number of living (morphologically unaffected) cells cultured in the medium containing 10.9 μM HgCl2 with the addition of mildronate + thiotriazolinum reached 87.0% of the control value taken as 100%. Therefore, under the toxic action of HgCl2 on cultured IMR-32 neuroblastoma cells, the combination of mildronate and thiotriazolinum demonstrated a significant protective effect, which was more intense than that of thiotriazolinum at its isolated application. Thiotriazolinum in concentrations of 0.001 to 0.1 mg/ml exerts rather moderate negative effects on the studied culture of neuroblastoma cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
T. W. Clarkson and L. Magos, “The toxicology of mercury and its chemical compounds,” Crit. Rev. Toxicol., 36, 609-662 (2006).
J. G. Dórea, “Low-dose mercury exposure in early life: Relevance of thimerosal to fetuses, newborns and infants,” Curr. Med. Chem., 20, 4060–4069 (2013).
R. F. Kamynsky, V. I. Primachenko, L. M. Sokurenko et al. “A study of impact of mercury chloride on myocardium in experiment” Georgian Med News, 251, 64-70. (2016)
I. M. Trachtenberg, Yu. B. Chaikovsky, and L. M. Sokurenko, “Morphological views on mercury intoxication pathogenesis (review of literature),” Mod. Probl. Toxicol., 1, 11-17 (2008).
J. P. Rooney, “The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury,” Toxicology, 234, 145-156 (2007).
I. I. Fomochkin, V. V. Kazakova, and P. N. Kolbasin “Clinical effectiveness of trental and thiotriazolinum in the treatment of acute pancreatitis,” Klin. Khirurg., 10, 10-12. (1999).
L. M. Sokurenko and Yu. B. Chaikovskii, “Protective effect of mildronate against toxic influence of mercury (II) chloride on cultured neuroblastoma cells,” Neurophysiology, 46, No. 3, 271-273 (2014).
I. Kalvinsh, Mildronate: The Mechanisms of Action and Perspectives of Use, Grindex, Riga (2002).
N. Sjakste, A. Gutaits, and I. Kalvinsh, “Mildronate: an antiischemic drug for neurological indications,” CNS Drug Rev., 11, 151-168 (2005).
E. Liepinsh, R. Vilskersts, D. Loca, et al., “Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction,” J. Cardiovasc. Pharmacol., 48, 314-319 (2006).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Sokurenko, L.M., Chaikovskii, Y.B. Protective Effects of Thiotriazolinum and Mildronate Against Mercury Chloride Toxicity in Neuroblastoma Cell Culture. Neurophysiology 48, 171–175 (2016). https://doi.org/10.1007/s11062-016-9585-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-016-9585-7